Clover Health Investments (Clover Health Investments) Earnings Yield (Joel Greenblatt) % : -93.46% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Clover Health Investments Earnings Yield (Joel Greenblatt) %?

Clover Health Investments's Enterprise Value for the quarter that ended in Dec. 2023 was $228 Mil. Clover Health Investments's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-213 Mil. Clover Health Investments's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2023 was -93.46%.

The historical rank and industry rank for Clover Health Investments's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

CLOV' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -11570.25 Med: -52.25 Max: 5424.6
Current: -227.27

During the past 5 years, the highest Earnings Yield (Joel Greenblatt) of Clover Health Investments was 5424.60%. The lowest was -11570.25%. And the median was -52.25%.

CLOV's Earnings Yield (Joel Greenblatt) % is ranked worse than
100% of 21 companies
in the Healthcare Plans industry
Industry Median: 5.63 vs CLOV: -227.27

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Clover Health Investments's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.

Clover Health Investments Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for Clover Health Investments's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover Health Investments Earnings Yield (Joel Greenblatt) % Chart

Clover Health Investments Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Earnings Yield (Joel Greenblatt) %

-48.78

-294.12

-93.46

Clover Health Investments Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Earnings Yield (Joel Greenblatt) %	Get a 7-Day Free Trial												-294.12	No Debt	322.58	-1,666.67	-93.46

Competitive Comparison of Clover Health Investments's Earnings Yield (Joel Greenblatt) %

For the Healthcare Plans subindustry, Clover Health Investments's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clover Health Investments's Earnings Yield (Joel Greenblatt) % Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Clover Health Investments's Earnings Yield (Joel Greenblatt) % falls into.

Clover Health Investments Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Clover Health Investmentss Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2023 is calculated as

Earnings Yield (Joel Greenblatt)	=	EBIT	/	Enterprise Value
	=	-213.354	/	227.6044092
	=	-93.74 %

Clover Health Investments's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-213 Mil.

Clover Health Investments (NAS:CLOV) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.

Be Aware

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.

Clover Health Investments Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Clover Health Investments's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.

Clover Health Investments (Clover Health Investments) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Clover Health Investments Corp (NAS:CLOV) » Definitions » Earnings Yield (Joel Greenblatt) %

Comparable Companies

BHG PFHO MRAI OSCR ALHC UNH ELV CI CVS HUM CNC MOH SZSE:000503 BSP:ODPV3 BSP:QUAL3 ROCO:6665 MIL:HI TSXV:NXG

Traded in Other Exchanges

7QD:Germany

Address

3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067

Website

https://www.cloverhealth.com

Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, & analyze health & behavioral data to improve medical outcomes & lower costs for patients. The Group has two operating segments. The insurance segment provides PPO(Preferred provider Organization) & HMO(Health Maintenance Organization) plans to Medicare Advantage members in several states & seeks to improve care & lower costs which generally provide access to a wide network of primary care providers, specialists, & hospitals. Non-insurance segment includes the Company's operations relating to CMS' DC (Direct Contracting) Model, which provides options aimed at reducing expenditures & preserving or enhancing the quality of care for beneficiaries.

Executives

Karen Soares	officer: General Counsel & Secretary	3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Clover Health Investments, Corp. /de	officer: Chief Technology Officer	3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Anna U Loengard	director	C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Andrew Toy	director, officer: Chief Executive Officer	C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Scott J. Leffler	officer: Chief Financial Officer	C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Brady Patrick Priest	officer: CEO of Home Care	C/O CLOVER HEALTH INVESTMENTS, CORP., FRANKLIN TN 37067
Demetrios L. Kouzoukas	director	C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN FL 37067
Aric R Sharp	officer: CEO of Value-Based Care	C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Wai Conrad	officer: Chief Technology Officer	3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Joseph Richards Martin	officer: General Counsel	C/O LOUISIANA-PACIFIC CORPORATION, 414 UNION STREET, SUITE 2000, NASHVILLE TN 37219
Vivek Garipalli	director, 10 percent owner, officer: Executive Chairperson	C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Carladenise Armbrister Edwards	director	C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Chelsea Clinton	director	C/O IAC 555 W 18TH STREET, NEW YORK NY 10011
Jamie L. Reynoso	officer: CEO of Medicare Advantage	C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Chamath Palihapitiya	10 percent owner, other: See Remarks	THE SOCIAL-CAPITAL PARTNERSHIP, L.L.C., 506 SANTA CRUZ AVENUE, SUITE 300, MENLO PARK CA 94025